Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III)
Condition: Epidermolysis Bullosa Interventions: Drug: allo-APZ2-OTS; Drug: Placebo Sponsor: RHEACELL GmbH & Co. KG Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials